Lack of share movement may be a good sign. Prior conference calls saw some share appreciation only to drop after no big news. This one may do the opposite.

Although I think for a real spring board to happen, the pharma or company the deal is with also needs to PR the information to get it in front of new eyes and big institutional investors who have never heard of cydy but are investors of the deal making company.

My thoughts anyway. Tomorrow is the day and we shall see.